Confusion and concern around hormone therapy have been common for years, especially for women navigating menopause and perimenopause. Recently, the FDA made a significant update, removing long-standing black box warnings from many hormone therapy treatments, a change that has sparked important conversations about safety, access, and women’s health.
To help break down what this update means for patients, WashU Medicine gynecologist Dr. Basia Blachut and WashU Medicine gynecologic oncologist Dr. Brooke Sanders spoke with KSDK’s Show Me St. Louis, answering common questions about hormone therapy, who may benefit, and how to make informed decisions alongside your doctor. As January comes to a close, they also emphasize the ongoing importance of routine cancer screenings in honor of Cervical Cancer Awareness Month.